Life Technologies (LIFE) Acquires Navigenics, Inc.

July 16, 2012 4:46 PM EDT
Life Technologies Corporation (NASDAQ: LIFE) announced the acquisition of Navigenics, Inc. This acquisition represents Life Technologies' first step in executing against a strategy to build out its molecular diagnostics business through internal development, partnerships and select acquisitions.

Navigenics, Inc. develops and commercializes genetics-based products and services to improve individual health. Navigenics educates and empowers individuals and their physicians by providing clinically actionable, personalized genetic insights about disease risk and medication response to catalyze behavior change and inform clinical decision-making. The company was founded by leading scientists and clinicians, and continues to advance genomic knowledge and adoption of molecular medicine through studies with leading academic centers. Among Navigenics' investors are Kleiner Perkins Caulfield and Byers, Mohr Davidow Ventures, and The Procter & Gamble Company (NYSE: PG).


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Mergers and Acquisitions